Arbeider i CRIStin


  • Rakaee, Mehrdad; Busund, Lill-Tove; Jamaly, Simin; Paulsen, Erna-Elise; Richardsen, Elin; Andersen, Sigve; Al-Saad, Samer; Bremnes, Roy M.; Dønnem, Tom; Kilvær, Thomas Karsten. Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry. Neoplasia 2019; Volum 21 (3). ISSN 1522-8002.s 282 - 293.s doi: 10.1016/j.neo.2019.01.005.

  • Richardsen, Elin; Andersen, Sigve; Al-Saad, Samer; Rakaee, Mehrdad; Nordby, Yngve; Pedersen, Mona Irene; Ness, Nora; Ingebriktsen, Lise M.; Fassina, Ambrogio; Tasken, Kristin Austlid; Mills, Ian Geoffrey; Dønnem, Tom; Bremnes, Roy M.; Rasmussen Busund, Lill-Tove. Low expression of miR-424-3p is highly correlated with clinical failure in prostate cancer. Scientific Reports 2019; Volum 9 (10662). ISSN 2045-2322.s 1 - 10.s doi: 10.1038/s41598-019-47234-0.

  • Ervik, Bente; Nordøy, Tone; Andersen, Sigve. Fruktene av "Lindring i nord". (fulltekst) Omsorg: Nordisk tidsskrift for Palliativ Medisin 2019; Volum 36 (1). ISSN 0800-7489.s 28 - 31.

  • Richardsen, Elin; Andersen, Sigve; Melbø-Jørgensen, Christian; Rakaee, Mehrdad; Ness, Nora; Al-Saad, Samer; Nordby, Yngve; Pedersen, Mona Irene; Dønnem, Tom; Bremnes, Roy M.; Rasmussen Busund, Lill-Tove. MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer. Scientific Reports 2019; Volum 93:386 (1). ISSN 2045-2322.s 1 - 9.s doi: 10.1038/s41598-018-36854-7.

  • Kiselev, Yury; Andersen, Sigve; Johannessen, Charles; Fjukstad, Bjørn; Olsen, Karina Standahl; Stenvold, Helge; Al-Saad, Samer; Dønnem, Tom; Richardsen, Elin; Bremnes, Roy M.; Busund, Lill-Tove. Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer. Scientific Reports 2018; Volum 8. ISSN 2045-2322.s doi: 10.1038/s41598-018-23417-z.

  • Grindstad, Thea K.W.; Richardsen, Elin; Andersen, Sigve; Skjefstad, Kaja Konstanse; Rakaee, Mehrdad; Dønnem, Tom; Ness, Nora; Nordby, Yngve; Bremnes, Roy M.; Al-Saad, Samer; Busund, Lill-Tove. Progesterone receptors in prostate cancer: Progesterone receptor B is the isoform associated with disease progression. Scientific Reports 2018; Volum 8:11358. ISSN 2045-2322.s 1 - 10.s doi: 10.1038/s41598-018-29520-5.

  • Rakaee, Mehrdad; Kilvær, Thomas Karsten; Dalen, Stig Manfred; Richardsen, Elin; Paulsen, Erna Elise; Hald, Sigurd; Al-Saad, Samer; Andersen, Sigve; Dønnem, Tom; Bremnes, Roy M.; Busund, Lill-Tove. Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer. Human Pathology 2018; Volum 79. ISSN 0046-8177.s 188 - 198.s doi: 10.1016/j.humpath.2018.05.017.

  • Skjefstad, Kaja Konstanse; Johannessen, Charles; Grindstad, Thea K.W.; Kilvær, Thomas Karsten; Paulsen, Erna Elise; Pedersen, Mona Irene; Dønnem, Tom; Andersen, Sigve; Bremnes, Roy M.; Richardsen, Elin; Al-Saad, Samer; Busund, Lill-Tove. A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer. Scientific Reports 2018; Volum 8. ISSN 2045-2322.s doi: 10.1038/s41598-018-26864-w.

  • Hald, Sigurd; Rakaee, Mehrdad; Martinez, Inigo Zubiavrre; Richardsen, Elin; Al-Saad, Samer; Paulsen, Erna Elise; Blix, Egil Støre; Kilvær, Thomas Karsten; Andersen, Sigve; Busund, Lill-Tove; Bremnes, Roy M.; Dønnem, Tom. LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival. Clinical Lung Cancer 2018; Volum 19 (3). ISSN 1525-7304.s 249 - 259.e2.s doi: 10.1016/j.cllc.2017.12.001.

  • Nordby, Yngve; Richardsen, Elin; Rakaee, Mehrdad; Ness, Nora; Dønnem, Tom; Patel, Hitendra R.H.; Busund, Lill-Tove; Bremnes, Roy M.; Andersen, Sigve. High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence. Scientific Reports 2017; Volum 7:43378. ISSN 2045-2322.s 1 - 9.s doi: 10.1038/srep43378.

  • Richardsen, Elin; Andersen, Sigve; Al-Saad, Samer; Rakaee, Mehrdad; Nordby, Yngve; Pedersen, Mona Irene; Ness, Nora; Grindstad, Thea K.W.; Movik, Ingeborg; Dønnem, Tom; Bremnes, Roy M.; Busund, Lill-Tove. Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort. PLOS ONE 2017; Volum 12:e0186852 (11). ISSN 1932-6203.s 1 - 13.s doi: 10.1371/journal.pone.0186852.

  • Nordby, Yngve; Richardsen, Elin; Ness, Nora; Dønnem, Tom; Patel, Hitendra R.H.; Busund, Lill-Tove; Bremnes, Roy M.; Andersen, Sigve. High miR-205 expression in normal epithelium is associated with biochemical failure - An argument for epithelial crosstalk in prostate cancer?. Scientific Reports 2017; Volum 7:16308. ISSN 2045-2322.s 1 - 10.s doi: 10.1038/s41598-017-16556-2.

  • Andersen, Sigve; Richardsen, Elin; Rakaee, Mehrdad; Bertilsson, Helena; Bremnes, Roy M.; Børset, Magne; Busund, Lill-Tove; Slørdahl, Tobias Schmidt. Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer. PLOS ONE 2017; Volum 12 (11). ISSN 1932-6203.s doi: 10.1371/journal.pone.0189000.

  • Paulsen, Erna-Elise; Kilvær, Thomas Karsten; Rakaee, Mehrdad; Richardsen, Elin; Hald, Sigurd; Andersen, Sigve; Busund, Lill-Tove; Bremnes, Roy M.; Dønnem, Tom. CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases. Cancer Immunology and Immunotherapy 2017; Volum 66. ISSN 0340-7004.s 1449 - 1461.s doi: 10.1007/s00262-017-2039-2.

  • Al-Saad, Samer; Richardsen, Elin; Kilvær, Thomas Karsten; Dønnem, Tom; Andersen, Sigve; Rakaee, Mehrdad; Bremnes, Roy M.; Busund, Lill-Tove. The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer. PLOS ONE 2017; Volum 12:e0181527 (7). ISSN 1932-6203.s 1 - 20.s doi: 10.1371/journal.pone.0181527.

  • Ness, Nora; Andersen, Sigve; Rakaee, Mehrdad; Nordbakken, Cecilie; Valkov, Andrey Yurjevich; Paulsen, Erna-Elise; Nordby, Yngve; Bremnes, Roy M.; Dønnem, Tom; Busund, Lill-Tove; Richardsen, Elin. The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort. OncoTarget 2017; Volum 8 (16). ISSN 1949-2553.s 26789 - 26801.s doi: 10.18632/oncotarget.15817.

  • Dønnem, Tom; Kilvær, Thomas Karsten; Andersen, Sigve; Richardsen, Elin; Paulsen, Erna-Elise; Hald, Sigurd; Al-Saad, Samer; Brustugun, Odd Terje; Helland, Åslaug; Lund-Iversen, Marius; Solberg, Steinar; Grønberg, Bjørn Henning; Wahl, Sissel Gyrid Freim; Helgeland, Lars; Fløtten, Øystein; Pohl, M; Al-Shibli, Khalid; Sandanger, Torkjel M; Pezzella, Francesco; Busund, Lill-Tove; Bremnes, Roy M.. Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer. Annals of Oncology 2016; Volum 27 (2). ISSN 0923-7534.s 225 - 232.s doi: 10.1093/annonc/mdv560.

  • Paulsen, Erna-Elise; Kilvær, Thomas Karsten; Rakaee, Mehrdad; Al-Saad, Samer; Hald, Sigurd; Andersen, Sigve; Richardsen, Elin; Ness, Nora; Busund, Lill-Tove; Bremnes, Roy M.; Dønnem, Tom. Assessing PDL-1 and PD-1 in non-small cell lung cancer: a novel immunoscore approach. Clinical Lung Cancer 2016; Volum 18 (2). ISSN 1525-7304.s 220 - 233.e8.s doi: 10.1016/j.cllc.2016.09.009.

  • Andersen, Sigve; Richardsen, Elin; Moi, Line; Dønnem, Tom; Nordby, Yngve; Ness, Nora; Eilertsen Holman, Marte; Bremnes, Roy M.; Busund, Lill-Tove. Fibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer – a multicenter (in situ hybridization)study. Scientific Reports 2016; Volum 6:36573. ISSN 2045-2322.s doi: 10.1038/srep36573.

  • Rakaee, Mehrdad; Busund, Lill-Tove; Paulsen, Erna-Elise; Richardsen, Elin; Al-Saad, Samer; Andersen, Sigve; Dønnem, Tom; Bremnes, Roy M.; Kilvær, Thomas Karsten. Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer. OncoTarget 2016; Volum 7 (44). ISSN 1949-2553.s 72184 - 72196.s doi: 10.18632/oncotarget.12360.

  • Grindstad, Thea; Skjefstad, Kaja; Andersen, Sigve; Ness, Nora; Nordby, Yngve; Al-Saad, Samer; Fismen, Silje; Dønnem, Tom; Rakaee, Mehrdad; Busund, Lill-Tove; Bremnes, Roy M.; Richardsen, Elin. Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcome. Scientific Reports 2016; Volum 6. ISSN 2045-2322.s doi: 10.1038/srep33114.

  • Bremnes, Roy M.; Busund, Lill-Tove; Kilvær, Thomas Karsten; Andersen, Sigve; Richardsen, Elin; Paulsen, Erna-Elise; Hald, Sigurd; Rakaee, Mehrdad; Cooper, Wendy A.; Kao, Steven C.; Dønnem, Tom. The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non-small cell lung cancer. Journal of Thoracic Oncology 2016; Volum 11 (6). ISSN 1556-0864.s 789 - 800.s doi: 10.1016/j.jtho.2016.01.015.

  • Skjefstad, Kaja; Grindstad, Thea; Rakaee, Mehrdad; Richardsen, Elin; Dønnem, Tom; Kilvær, Thomas Karsten; Andersen, Sigve; Bremnes, Roy M.; Busund, Lill-Tove; Al-Saad, Samer. Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer. Steroids 2016; Volum 113. ISSN 0039-128X.s 5 - 13.s doi: 10.1016/j.steroids.2016.05.008.

  • Pøhl, Mette; Olsen, Karen Ege; Holst, Rene; Dønnem, Tom; Busund, Lill-Tove; Bremnes, Roy M.; Al-Saad, Samer; Andersen, Sigve; Richardsen, Elin; Ditzel, Henrik J; Hansen, Olfred. Keratin 34betaE12/keratin7 expression is a prognostic factor of cancer-specific and overall survival in patients with early stage non-small cell lung cancer. Acta Oncologica 2016; Volum 55 (2). ISSN 0284-186X.s 167 - 177.s doi: 10.3109/0284186X.2015.1049291.

  • Grindstad, Thea; Andersen, Sigve; Al-Saad, Samer; Dønnem, Tom; Kiselev, Yury; Melbø-Jørgensen, Christian; Skjefstad, Kaja; Busund, Lill-Tove; Bremnes, Roy M.; Richardsen, Elin. High progesterone receptor expression in prostate cancer is associated with clinical failure. PLOS ONE 2015; Volum 10:e0116691 (2). ISSN 1932-6203.s doi: 10.1371/journal.pone.0116691.

  • Nordby, Yngve; Andersen, Sigve; Richardsen, Elin; Ness, Nora; Al-Saad, Samer; Melbø-Jørgensen, Christian; Patel, Hitendra R.H.; Dønnem, Tom; Busund, Lill-Tove; Bremnes, Roy M.. Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy. The Prostate 2015; Volum 75 (15). ISSN 0270-4137.s 1682 - 1693.s doi: 10.1002/pros.23048.

  • Richardsen, Elin; Ness, Nora; Melbø-Jørgensen, Christian; Johannessen, Charles; Grindstad, Thea; Nordbakken, Cecilie; Al-Saad, Samer; Andersen, Sigve; Dønnem, Tom; Nordby, Yngve; Bremnes, Roy M.; Busund, Lill-Tove. The Prognostic Significance of CXCL16 and Its Receptor C-X-C Chemokine Receptor 6 in Prostate Cancer. American Journal of Pathology 2015; Volum 185 (10). ISSN 0002-9440.s 2722 - 2730.s doi: 10.1016/j.ajpath.2015.06.013.

  • Paulsen, Erna-Elise; Kilvær, Thomas Karsten; Rakaeekhanehkenari, Mehrdad; Johansen Maurseth, Ramona; Al-Saad, Samer; Hald, Sigurd; Al-Shibli, Khalid; Andersen, Sigve; Richardsen, Elin; Busund, Lill-Tove; Bremnes, Roy M.; Dønnem, Tom. CD45RO+ memory T lymphocytes – a candidate marker for TNM-immunoscore in squamous non-small cell lung cancer. Neoplasia 2015; Volum 17 (11). ISSN 1522-8002.s 839 - 848.s doi: 10.1016/j.neo.2015.11.004.

  • Andersen, Sigve; Solstad, Ørjan; Moi, Line Leonore Haugan; Dønnem, Tom; Eilertsen, Marte; Nordby, Yngve; Ness, Nora; Richardsen, Elin; Busund, Lill-Tove; Bremnes, Roy M.. Organized metabolic crime in prostate cancer: The coexpression of MCT1 in tumor and MCT4 in stroma is an independent prognosticator for biochemical failure. Urologic Oncology 2015; Volum 33 (8). ISSN 1078-1439.s 338.e9 - 338.e17.s doi: 10.1016/j.urolonc.2015.05.013.

  • Skjefstad, Kaja; Richardsen, Elin; Dønnem, Tom; Andersen, Sigve; Kiselev, Yury; Grindstad, Thea; Hald, Sigurd; Al-Shibli, Khalid; Bremnes, Roy M.; Busund, Lill-Tove; Al-Saad, Samer. The prognostic role of progesterone receptor expression in non-small cell lung cancer patients: Gender-related impacts and correlation with disease-specific survival. Steroids 2015; Volum 98. ISSN 0039-128X.s 29 - 36.s doi: 10.1016/j.steroids.2015.01.020.

  • Hald, Sigurd; Kiselev, Yury; Al-Saad, Samer; Richardsen, Elin; Johannessen, Charles; Eilertsen, Marte; Kilvær, Thomas Karsten; Al-Shibli, Khalid; Andersen, Sigve; Busund, Lill-Tove; Bremnes, Roy M.; Dønnem, Tom. Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: Combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. BMC Cancer 2015; Volum 15 (441). ISSN 1471-2407.s doi: 10.1186/s12885-015-1446-z.

  • Dønnem, Tom; Hald, Sigurd; Paulsen, Erna-Elise; Richardsen, Elin; Al-Saad, Samer; Kilvær, Thomas Karsten; Brustugun, Odd Terje; Helland, Åslaug; Lund-Iversen, Marius; Poehl, Mette; Olsen, Karen Ege; Ditzel, Henrik J.; Hansen, Olfred; Al-Shibli, Khalid; Kiselev, Yury; Sandanger, Torkjel M; Andersen, Sigve; Pezzella, Francesco; Bremnes, Roy M.; Busund, Lill-Tove. Stromal CD8+ T-cell density - A promising supplement to TNM staging in non-small cell lung cancer. Clinical Cancer Research 2015; Volum 21 (11). ISSN 1078-0432.s 2635 - 2643.s doi: 10.1158/1078-0432.CCR-14-1905.

  • Eilertsen, Marte; Andersen, Sigve; Al-Saad, Samer; Richardsen, Elin; Stenvold, Helge; Hald, Sigurd; Al-Shibli, Khalid; Dønnem, Tom; Busund, Lill-Tove; Bremnes, Roy M.. Positive prognostic impact of miR-210 in non-small cell lung cancer. Lung Cancer 2014; Volum 83 (2). ISSN 0169-5002.s 272 - 278.s doi: 10.1016/j.lungcan.2013.11.005.

  • Eilertsen, Marte; Andersen, Sigve; Al-Saad, Samer; Kiselev, Yury; Dønnem, Tom; Stenvold, Helge; Pettersen, Ingvild; Al-Shibli, Khalid; Richardsen, Elin; Busund, Lill-Tove; Bremnes, Roy M.. Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival. PLOS ONE 2014; Volum 9 (9). ISSN 1932-6203.s doi: 10.1371/journal.pone.0105038.

  • Melbø-Jørgensen, Christian Nordahl; Ness, Nora; Andersen, Sigve; Valkov, Andrey Yurjevich; Dønnem, Tom; Al-Saad, Samer; Kiselev, Yury; Berg, Thomas; Nordby, Yngve; Bremnes, Roy M.; Busund, Lill-Tove; Richardsen, Elin. Stromal expression of miR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6. (fulltekst) PLOS ONE 2014; Volum 9:e113039 (11). ISSN 1932-6203.s doi: 10.1371/journal.pone.0113039.

  • Andersen, Sigve; Richardsen, Elin; Nordby, Yngve; Ness, Nora; Størkersen, Øystein; Al-Shibli, Khalid; Dønnem, Tom; Bertilsson, Helena; Busund, Lill-Tove; Angelsen, Anders; Bremnes, Roy M.. Disease-specific outcomes of Radical Prostatectomies in Northern Norway; A case for the impact of perineural infiltration and postoperative PSA-doubling time. BMC Urology 2014; Volum 14 (1). ISSN 1471-2490.s doi: 10.1186/1471-2490-14-49.

  • Ness, Nora; Andersen, Sigve; Valkov, Andrey Yurjevich; Nordby, Yngve; Dønnem, Tom; Al-Saad, Samer; Busund, Lill-Tove; Bremnes, Roy M.; Richardsen, Elin. Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancer. The Prostate 2014; Volum 74 (14). ISSN 0270-4137.s 1452 - 1461.s doi: 10.1002/pros.22862.

  • Stenvold, Helge; Dønnem, Tom; Andersen, Sigve; Al-Saad, Samer; Busund, Lill-Tove; Bremnes, Roy M.. Stage and tissue-specific prognostic impact of miR-182 in NSCLC. BMC Cancer 2014; Volum 14:138. ISSN 1471-2407.s doi: 10.1186/1471-2407-14-138.

  • Stenvold, Helge; Dønnem, Tom; Andersen, Sigve; Al-Saad, Samer; Valkov, Andrey Yurjevich; Pedersen, Mona Irene; Busund, Lill-Tove; Bremnes, Roy M.. High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome. BMC Clinical Pathology 2014; Volum 14. ISSN 1472-6890.s doi: 10.1186/1472-6890-14-9.

  • Hald, Sigurd; Bremnes, Roy M.; Al-Shibli, Khalid; Al-Saad, Samer; Andersen, Sigve; Stenvold, Helge; Busund, Lill-Tove; Dønnem, Tom. CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy. Lung Cancer 2013; Volum 80 (2). ISSN 0169-5002.s 209 - 215.s doi: 10.1016/j.lungcan.2012.12.026.

  • Stenvold, Helge; Dønnem, Tom; Andersen, Sigve; Al-Saad, Samer; Al-Shibli, Khalid Ibrahim; Busund, Lill-Tove; Bremnes, Roy M.. Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: Correlation with a favorable clinical outcome. Lung Cancer 2012; Volum 75 (2). ISSN 0169-5002.s 235 - 241.s doi: 10.1016/j.lungcan.2011.06.010.

  • Dønnem, Tom; Bremnes, Roy M.; Busund, Lill-Tove; Andersen, Sigve; Pezzella, F. Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer. Journal of Thoracic Disease 2012; Volum 4 (2). ISSN 2072-1439.s 212 - 213.s doi: 10.3978/j.issn.2072-1439.2012.03.02.

  • Smeland, Eivind; Kilvær, Thomas Karsten; Sørbye, Sveinung Wergeland; Valkov, Andrey Yurjevich; Andersen, Sigve; Bremnes, Roy M.; Busund, Lill-Tove; Dønnem, Tom. Prognostic Impacts of Hypoxic Markers in Soft Tissue Sarcoma. Sarcoma 2012; Volum 2012. ISSN 1357-714X.s doi: 10.1155/2012/541650.

  • Eilertsen, Marte; Pettersen, ingvild; Andersen, Sigve; Martinez, Inigo Zubiavrre; Dønnem, Tom; Busund, Lill-Tove; Bremnes, Roy M.. In NSCLC, VEGF-A Response to Hypoxia May Differ between Squamous Cell and Adenocarcinoma Histology. (sammendrag) Anticancer Research 2012; Volum 32 (11). ISSN 0250-7005.s 4729 - 4736.

  • Dønnem, Tom; Ervik, Bente; Magnussen, Kathrine; Andersen, Sigve; Pastow, Doris Ruth; Andreassen, Sissel; Nørstad, Tone; Helbekkmo, Nina; Bremnes, Roy M.; Nordøy, Tone. Bridging the distance: a prospective tele-oncology study in Northern Norway. Supportive Care in Cancer 2012; Volum 20 (9). ISSN 0941-4355.s 2097 - 2103.s doi: 10.1007/s00520-011-1319-1.

  • Dønnem, Tom; Fenton, Christopher Graham; Lønvik, Kenneth; Berg, Thomas; Eklo, Katrine; Andersen, Sigve; Stenvold, Helge; Al-Shibli, Khalid Ibrahim; Al-Saad, Samer; Bremnes, Roy M.; Busund, Lill-Tove. MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer. PLOS ONE 2012; Volum 7 (1). ISSN 1932-6203.s doi: 10.1371/journal.pone.0029671.

  • Bremnes, Roy M.; Al-Shibli, Khalid Ibrahim; Dønnem, Tom; Sirera, Rafael; Al-Saad, Samer; Andersen, Sigve; Stenvold, Helge; Camps, Carlos; Busund, Lill-Tove Rasmussen. The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis Emphasis on Non-small Cell Lung Cancer. Journal of Thoracic Oncology 2011; Volum 6 (1). ISSN 1556-0864.s 209 - 217.s doi: 10.1097/JTO.0b013e3182037b76.

  • Bremnes, Roy M.; Al-Shibli, Khalid Ibrahim; Dønnem, Tom; Sirera, Rafael; Al-Saad, Samer; Andersen, Sigve; Stenvold, Helge; Camps, Carlos; Busund, Lill-Tove. The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis. Journal of Thoracic Oncology 2011; Volum 6 (4). ISSN 1556-0864.s 824 - 833.

  • Andersen, Sigve; Dønnem, Tom; Stenvold, Helge; Al-Saad, Samer; Al-Shibli, Khalid Ibrahim; Busund, Lill-Tove; Bremnes, Roy M.. Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival. PLOS ONE 2011; Volum 6 (8). ISSN 1932-6203.s doi: 10.1371/journal.pone.0023847.

  • Andersen, Sigve; Dønnem, Tom; Al-Saad, Samer; Al-Shibli, Khalid Ibrahim; Stenvold, Helge; Busund, Lill-Tove; Bremnes, Roy M.. Correlation and Coexpression of HIFs and NOTCH Markers in NSCLC. Anticancer Research 2011; Volum 31 (5). ISSN 0250-7005.s 1603 - 1606.

  • Andersen, Sigve; Dønnem, Tom; Al-Shibli, Khalid Ibrahim; Al-Saad, Samer; Stenvold, Helge; Busund, Lill-Tove; Bremnes, Roy M.. Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma: VEGF-A Impact Is Strongly Associated with Ang-2. PLOS ONE 2011; Volum 6 (5). ISSN 1932-6203.s doi: 10.1371/journal.pone.0019773.

  • Dønnem, Tom; Andersen, Sigve; Al-Saad, Samer; Al-Shibli, Khalid Ibrahim; Busund, Lill-Tove; Bremnes, Roy M.. Prognostic Impact of Angiogenic Markers in Non-Small-Cell Lung Cancer is Related to Tumor Size. Clinical Lung Cancer 2011; Volum 12 (2). ISSN 1525-7304.s 106 - 115.s doi: 10.1016/j.cllc.2011.03.005.

  • Dønnem, Tom; Lønvik, Kenneth; Eklo, Katrine; Berg, Thomas; Sørbye, Sveinung Wergeland; Al-Shibli, Khalid Ibrahim; Al-Saad, Samer; Andersen, Sigve; Stenvold, Helge; Bremnes, Roy M.; Busund, Lill-Tove. Independent and Tissue-Specific Prognostic Impact of miR-126 in Nonsmall Cell Lung Cancer. Cancer 2011; Volum 117 (14). ISSN 0008-543X.s 3193 - 3200.s doi: 10.1002/cncr.25907.

  • Andersen, Sigve; Eilertsen, Marte; Dønnem, Tom; Al-Shibli, Khalid Ibrahim; Al-Saad, Samer; Busund, Lill-Tove; Bremnes, Roy M.. Diverging prognostic impacts of hypoxic markers according to NSCLC histology. Lung Cancer 2011; Volum 72 (3). ISSN 0169-5002.s 294 - 302.s doi: 10.1016/j.lungcan.2010.10.006.

  • Dønnem, Tom; Eklo, Katrine; Berg, Thomas; Sørbye, Sveinung Wergeland; Lønvik, Kenneth; Al-Saad, Samer; Al-Shibli, Khalid Ibrahim; Andersen, Sigve; Stenvold, Helge; Bremnes, Roy M.; Busund, Lill-Tove. Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization. Journal of Translational Medicine 2011; Volum 9. ISSN 1479-5876.s doi: 10.1186/1479-5876-9-6.

  • Bremnes, Roy M.; Dønnem, Tom; Al-Saad, Samer; Al-Shibli, Khalid Ibrahim; Andersen, Sigve; Sirera, Rafael; Camps, Carlos; Martinez, Inigo Zubiavrre; Busund, Lill-Tove Rasmussen. The Role of Tumor Stroma in Cancer Progression and Prognosis Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer. Journal of Thoracic Oncology 2011; Volum 6 (1). ISSN 1556-0864.s 209 - 217.s doi: 10.1097/JTO.0b013e3181f8a1bd.

  • Dønnem, Tom; Al-Shibli, Khalid Ibrahim; Andersen, Sigve; Al-Saad, Samer; Busund, Lill-Tove Rasmussen; Bremnes, Roy M.. Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer. Cancer 2010; Volum 116. ISSN 0008-543X.s 4318 - 4325.s doi: 10.1002/cncr.25333.

  • Dønnem, Tom; Andersen, Sigve; Al-Shibli, Khalid Ibrahim; Al-Saad, Samer; Busund, Lill-Tove Rasmussen; Bremnes, Roy M.. Prognostic Impact of Notch Ligands and Receptors in Nonsmall Cell Lung Cancer Coexpression of Notch-1 and Vascular Endothelial Growth Factor-A Predicts Poor Survival. Cancer 2010; Volum 116 (24). ISSN 0008-543X.s 5676 - 5685.s doi: 10.1002/cncr.25551.

  • Al-Saad, Samer; Al-Shibli, Khalid; Dønnem, Tom; Andersen, Sigve; Bremnes, Roy M.; Busund, Lill-Tove Rasmussen. Clinical Significance of Epidermal Growth Factor Receptors in Non-small Cell Lung Cancer and a Prognostic Role for HER2 Gene Copy Number in Female Patients. Journal of Thoracic Oncology 2010; Volum 5 (10). ISSN 1556-0864.s 1536 - 1543.s doi: 10.1097/JTO.0b013e3181ea510a.

  • Al-Shibli, Khalid Ibrahim; Al-Saad, Samer; Andersen, Sigve; Dønnem, Tom; Bremnes, Roy M.; Busund, Lill-Tove Rasmussen. The prognostic value of intraepithelial and stromal CD3-, CD117-and CD138-positive cells in non-small cell lung carcinoma. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS) 2010; Volum 118 (5). ISSN 0903-4641.s 371 - 382.s doi: 10.1111/j.1600-0463.2010.02609.x.

  • Andersen, Sigve; Dønnem, Tom; Al-Saad, Samer; Al-Shibli, Khalid Ibrahim; Busund, Lill-Tove Rasmussen; Bremnes, Roy M.. Angiogenic Markers Show High Prognostic Impact on Survival in Marginally Operable Non-small Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy. Journal of Thoracic Oncology 2009; Volum 4 (4). ISSN 1556-0864.s 463 - 471.

  • Dønnem, Tom; Al-Saad, Samer; Al-Shibli, Khalid Ibrahim; Andersen, Sigve; Busund, Lill-Tove Rasmussen; Bremnes, Roy M.. Prognostic impact of platelet-derived growth facors in non-small cell lung cancer tumor and stromal cells. Journal of Thoracic Oncology 2008; Volum 3. ISSN 1556-0864.s 963 - 970.

  • Dønnem, Tom; Al-Saad, Samer; Al-Shibli, Khalid Ibrahim; Andersen, Sigve; Busund, Lill-Tove Rasmussen; Bremnes, Roy M.. Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells. Journal of Thoracic Oncology 2008; Volum 3 (9). ISSN 1556-0864.s 963 - 970.

  • Borch, Kristin Benjaminsen; Andersen, Sigve; Oldervoll, Line Merethe; Berntsen, Sveinung. Hva vet onkologer om fysisk aktivitet og kreft?. KreftRehabiliteringskonferansen 2019 2019-04-09 - 2019-04-09 2019.

  • Andersen, Sigve; Dønnem, Tom. Krafttak mot kreft. 2019.

  • Skjefstad, Kaja Konstanse; Grindstad, Thea K.W.; Rakaee, Mehrdad; Richardsen, Elin; Dønnem, Tom; Kilvær, Thomas Karsten; Andersen, Sigve; Bremnes, Roy M.; Busund, Lill-Tove; Al-Saad, Samer. Corrigendum to "Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer" [Steroids 113 (2016) 5-13]. Steroids 2018; Volum 130. ISSN 0039-128X.s 36 - 37.s doi: 10.1016/j.steroids.2017.11.010.

  • Kaasa, Stein; Andersen, Sigve; Bahus, Marianne Klungland; Broen, Peder; Farsund, Helge; Flovik, Anne Marie; Hagerup, Søren Vincent; Husby, Bodil; Pedersen, Natasha; Rønsen, Astrid; Schjødt, Borrik; Slaaen, Joran. NOU 2017:16 : På liv og død : Palliasjon til alvorlig syke og døende : utredning fra utvalg oppnevnt ved kongelig resolusjon 11. mai 2016. Avgitt til Helse- og omsorgsdepartementet 20. desember 2017. (fulltekst) 2017 (2017:16) ISBN 978-82-583-1343-1. ISSN 0333-2306.s 141 - 154.

  • Andersen, Sigve. Vi trenger et helsevesen som er mer opptatt av døden. (fulltekst) 2017.

  • Andersen, Sigve. EXIPOX pilot studie. Brukermedvirkningsmøte med kreftforeningen 2017-11-03 - 2017-11-03 2017.

  • Andersen, Sigve. Langt kommet Prostatakreft – hva gjør vi nå?. Folkemøte 2017-11-22 - 2017-11-22 2017.

  • Andersen, Sigve; Dønnem, Tom; Trosten, Bodil; Larsen, Kari Margrethe; Nordøy, Tone; Ervik, Bente. Palliative indicators in a university hospital - a cross-sectional prevalence study combined with ESAS-r symptom assesment and follow up of death. 15th World Congress of the European Association for Palliative Care 2017-05-18 - 2017-05-20 2017.

  • Andersen, Sigve; Ervik, Bente. Gir vi god nok lindrende behandling i Nord-Norge?. Bladet Nordlys 2016.

  • Andersen, Sigve; Borch, Kristin Benjaminsen. Exercise for improving ­Prostate oxygenation in prostate tumores (EXIPOX)-Study – a pilot study exploring exercise as a way of improving cure with radical radiotherapy. Snakk med en forsker 2016-09-29 - 2016-09-29 2016.

  • Andersen, Sigve. Langtkommet prostatakreft. Åpent folkemøte om prostatakreft 2015-11-17 - 2015-11-17 2015.

  • Andersen, Sigve; Eggen, Tormod; Dønnem, Tom; Busund, Lill-Tove; Bremnes, Roy M.. Sudden Death by an Atrial-Esophageal Fistulae. Journal of Thoracic Oncology 2013; Volum 8 (2). ISSN 1556-0864.s 254 - 254.s doi: 10.1097/JTO.0b013e31827ce3a9.

  • Al-Saad, Samer; Al-Shibli, Khalid Ibrahim; Dønnem, Tom; Andersen, Sigve; Bremnes, Roy M.; Busund, Lill-Tove Rasmussen. Simultaneous Expression of EGFR, HER2, HER3 and HER4 in Non-Small Cell Lung Cancer NSCLC: Correlation With Clinical Outcome and a Comparison Between Immunohistochemical Protein Expression and Silver In Situ Hybridization (SISH) For Detection of HER2 Gene Amplification. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS) 2010; Volum 118 (3). ISSN 0903-4641.s 245 - 246.

  • Andersen, Sigve; Eilertsen, Marte; Dønnem, Tom; Al-Saad, Samer; Al-Shibli, Khalid Ibrahim; Busund, Lill-Tove Rasmussen; Bremnes, Roy M.. Diverging prognostic impacts of hypoxic markers in histologic non-small cell lung cancer (NSCLC) subtypes. Journal of Thoracic Oncology 2009; Volum 4 (9). ISSN 1556-0864.s S386 - S387.